CCG-100602

Overview

CCG-100602 is a specific inhibitor of myocardin-related transcription factor A/serum response factor ( MRTF-A/SRF ) signaling. CCG-100602 specifically block MRTF-A nuclear localization and thus inhibit the fibrogenic transcription factor SRF.

Application

Products | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Ras

Product Information

• Catalog No.: HY-120855
• CAS No.: 1207113-88-9
• Molecular Formula: C21H17ClF6N2O2
• Molecular Weight: 478.82
• Purity: 99.29%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 0.83 mg/mL (1.73 mM); Clear solution
• Availability: In-stock

Source

Original product source